Imidazoquinolines-substituted amides.

A pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I): wherein R1 is -alkyl-NR3-CO-R4 or -alkenyl-NR3-CO-R4 wherein R4 is aryl, heteroaryl, alkyl or alkenyl, may be each unsubstituted or substituted with one or more substituents selected from the group consisting of: -alkyl; I -alkenyl; I -alkynyl; - (alkyl) 0-1 aryl; - (alkyl) 0-1 (substituted aryl); - (alkyl) 0-1-heteroaryl; - (alkyl) 0-1 (substituted heteroaryl); -O-alkyl; -O- (alkyl) 0-1 aryl; -O- (alkyl) 0-1 (substituted aryl); -O- (alkyl) 0-1 heteroaryl; -O- (alkyl) 0-1 (substituted heteroaryl); -CO-aryl; -CO- (substituted aryl); -CO-heteroaryl; -CO- (substituted heteroaryl); -COOH; -CO-O-alkyl; -CO-; -S (O) 0-2-alkyl; -S (O) 0-2- (alkyl) 0-1 aryl; -S (O) 0-2- (alkyl) 0-1 (substituted aryl); -S (O) 0-2- (alkyl) 0-1-heteroaryl; -S (O) 0-2- (alkyl) 0-1 (substituted heteroaryl); -P (O) (OR3) 2; -NR3-CO-O-alkyl; -N 3; -halogen; -NO 2; --CN; I -haloalkyl; -O-haloalkyl; -CO-haloalkyl; OH; -SH; and where alkyl, alkenyl or heterocyclyl, oxo.